CSIMarket


Laboratory Corporation Of America Holdings  (LH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

LH's Net Income Growth by Quarter and Year

Laboratory Of America Holdings's Net Income results by quarter and year




LH Net Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 938.60 227.30 158.30
III Quarter September 587.80 703.70 221.00 319.00
II Quarter June 468.00 231.60 190.70 234.10
I Quarter March 770.10 -316.90 185.90 172.50
FY   1,825.90 1,557.00 824.90 883.90



LH Net Income third quarter 2021 Y/Y Growth Comment
Laboratory Corporation Of America Holdings reported decline in Net Income in the third quarter by -16.47% to $ 587.80 millions, from the same quarter in 2020.
The contraction in the third quarter Laboratory Corporation Of America Holdings's Net Income compares unfavorably to the Company's average Net Income growth of 3.38%.

Looking into third quarter results within Medical Laboratories industry 8 other companies have achieved higher Net Income growth. While Laboratory Corporation Of America Holdings' s Net Income fall of -16.47% ranks overall at the positon no. 1152 in the third quarter.




LH Net Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 312.93 % 43.59 % -13.69 %
III Quarter September -16.47 % 218.42 % -30.72 % 68.87 %
II Quarter June 102.07 % 21.45 % -18.54 % 21.61 %
I Quarter March - - 7.77 % -4.06 %
FY   - 88.75 % -6.67 % 18.71 %

Financial Statements
Laboratory Of America Holdings's third quarter 2021 Net Income $ 587.80 millions LH's Income Statement
Laboratory Of America Holdings's third quarter 2020 Net Income $ 703.70 millions Quarterly LH's Income Statement
New: More LH's historic Net Income Growth >>


LH Net Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 33.38 % 2.85 % -50.38 %
III Quarter September 25.6 % 203.84 % 15.89 % 36.27 %
II Quarter June -39.23 % - 2.58 % 35.71 %
I Quarter March -17.95 % - 17.44 % -5.94 %
FY (Year on Year)   - 88.75 % -6.67 % 18.71 %




Net Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #86
Overall #1152

Net Income Y/Y Growth Statistics
High Average Low
132.98 % 3.38 % -75.86 %
(Sep 30 2020)   (Dec 31 2013)
Net Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #86
Overall #1152
Net Income Y/Y Growth Statistics
High Average Low
132.98 % 3.38 % -75.86 %
(Sep 30 2020)   (Dec 31 2013)

Net Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Laboratory Of America Holdings's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
16770 % 279.24 % -99.16 %
(Jun 30 2015)  


LH's III. Quarter Q/Q Net Income Comment
Laboratory Corporation Of America Holdings achieved in the III. Quarter 2021 below company average Net Income jump of 25.6% quarter on quarter, to $ 587.80 millions.

Within Medical Laboratories industry 3 other companies have achieved higher Net Income quarter on quarter growth. While Laboratory Of America Holdings's Net Income growth quarter on quarter, overall rank is 378.


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #4
Healthcare Sector #33
Overall #378
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #4
Healthcare Sector #33
Overall #378
Net Income Q/Q Growth Statistics
High Average Low
16770 % 279.24 % -99.16 %
(Jun 30 2015)  


LH's III. Quarter Q/Q Net Income Comment
Laboratory Corporation Of America Holdings achieved in the III. Quarter 2021 below company average Net Income jump of 25.6% quarter on quarter, to $ 587.80 millions.

Within Medical Laboratories industry 3 other companies have achieved higher Net Income quarter on quarter growth. While Laboratory Of America Holdings's Net Income growth quarter on quarter, overall rank is 378.


Laboratory Of America Holdings's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
Cumulative Net Income 12 Months Ending $ 2,764.50 $ 2,880.40 $ 2,644.00 $ 1,557.00 $ 845.70
Y / Y Net Income Growth (TTM) 226.89 % 693.5 % 720.86 % 88.75 % 11.88 %
Year on Year Net Income Growth Overall Ranking # 161 # 65 # 61 # 172 # 689
Seqeuential Net Income Change (TTM) -4.02 % 8.94 % 69.81 % 84.11 % 132.98 %
Seq. Net Income Growth (TTM) Overall Ranking # 1152 # 1201 # 303 # 127 # 95




Cumulative Net Income growth Comment
Assuming the Laboratory Of America Holdings's fiscal year would have ended in Sep 30 2021, Laboratory Of America Holdings would have reprted above average annual Net Income surge of 226.89% year on year, of $ 2,765 millions.
This marks a slow-down of the companys growth trends and from the 693.5% surge in Jun 30 2021.

Among companies within the Healthcare sector 11 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 65 to 161.

Net Income TTM Q/Q Growth Statistics
High Average Low
132.98 %
3.38 %
-75.86 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 9
Healthcare Sector # 12
Overall # 161

Net Income TTM Y/Y Growth Statistics
High Average Low
720.86 %
31.68 %
-76.5 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 86
S&P 500 # 1152
Cumulative Net Income growth Comment
Assuming the Laboratory Of America Holdings's fiscal year would have ended in Sep 30 2021, Laboratory Of America Holdings would have reprted above average annual Net Income surge of 226.89% year on year, of $ 2,765 millions.
This marks a slow-down of the companys growth trends and from the 693.5% surge in Jun 30 2021.

Among companies within the Healthcare sector 11 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 65 to 161.

Net Income TTM Q/Q Growth Statistics
High Average Low
132.98 %
3.38 %
-75.86 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 9
Healthcare Sector # 12
Overall # 161

Net Income TTM Y/Y Growth Statistics
High Average Low
720.86 %
31.68 %
-76.5 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 86
S&P 500 # 1152




Other Net Income Growth
Medical Laboratories Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
LH's Net Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for LH's Competitors
Net Income Growth for Laboratory Of America Holdings's Suppliers
Net Income Growth for LH's Customers

You may also want to know
LH's Annual Growth Rates LH's Profitability Ratios LH's Asset Turnover Ratio LH's Dividend Growth
LH's Roe LH's Valuation Ratios LH's Financial Strength Ratios LH's Dividend Payout Ratio
LH's Roa LH's Inventory Turnover Ratio LH's Growth Rates LH's Dividend Comparisons



Companies with similar Net Income surge for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2021
Dexcom Inc -1.80%$ -1.801 millions
Owens and Minor Inc -4.24%$ -4.236 millions
United Therapeutics Corporation-4.96%$ -4.965 millions
Amgen Inc -6.78%$ -6.779 millions
Quidel Corporation-7.11%$ -7.111 millions
Eli Lilly And Company-8.13%$ -8.135 millions
Abiomed Inc -8.45%$ -8.455 millions
Universal Health Services Inc -10.13%$ -10.126 millions
U S Physical Therapy Inc-10.40%$ -10.404 millions
Quest Diagnostics Inc-10.83%$ -10.829 millions
Lemaitre Vascular Inc-13.43%$ -13.430 millions
Vyne Therapeutics Inc -13.87%$ -13.875 millions
Semler Scientific inc -14.71%$ -14.714 millions
Pro dex Inc -15.89%$ -15.889 millions
Laboratory Corporation Of America Holdings-16.47%$ -16.470 millions
Bristol Myers Squibb Co-17.36%$ -17.359 millions
Electromed Inc -17.98%$ -17.984 millions
Nature s Sunshine Products inc -23.87%$ -23.867 millions
Immune Therapeutics Inc -23.97%$ -23.971 millions
Petmed Express Inc-24.52%$ -24.524 millions
Co diagnostics Inc -27.05%$ -27.051 millions
Elite Pharmaceuticals Inc -27.59%$ -27.587 millions
Collegium Pharmaceutical inc -28.71%$ -28.708 millions
Biodelivery Sciences International Inc -28.92%$ -28.925 millions
Stryker Corp-29.47%$ -29.469 millions
Fitlife Brands Inc -31.61%$ -31.611 millions
Hologic Inc-33.29%$ -33.293 millions
Msa Safety Inc-33.33%$ -33.332 millions
Steris Plc-34.32%$ -34.321 millions
Viemed Healthcare Inc -36.20%$ -36.198 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IXAQU's Profile

Stock Price

IXAQU's Financials

Business Description

Fundamentals

Charts & Quotes

IXAQU's News

Suppliers

IXAQU's Competitors

Customers & Markets

Economic Indicators

IXAQU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071